Clinical Trial Update: Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer [NA]

View source ↗

Summary

This completed clinical trial evaluated sentinel lymph node biopsy and primary tumor gene expression profiling to detect axillary lymph node metastases in women…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Breast Cancer | NA | Status: COMPLETED